Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Hein van Onzenoort
Risk of Major Bleeding and Stroke Associated With the Use of Vitamin K Antagonists, Nonvitamin K Antagonist Oral Anticoagulants and Aspirin in Patients With Atrial Fibrillation: A Cohort Study
British Journal of Clinical Pharmacology
Pharmacology
Related publications
Healthcare Costs of Stroke and Major Bleeding in Patients With Atrial Fibrillation Treated With Non–vitamin K Antagonist Oral Anticoagulants
Journal of Medical Economics
Health Policy
Impact of Non-Vitamin K Antagonist Oral Anticoagulants on Intracranial Bleeding in Asian Patients With Non-Valvular Atrial Fibrillation
Circulation Journal
Medicine
Cardiovascular Medicine
Cardiology
Comparative Effectiveness and Safety of Non-Vitamin K Antagonist Oral Anticoagulants and Warfarin in Patients With Atrial Fibrillation: Propensity Weighted Nationwide Cohort Study
British Medical Journal
Medicine
Effectiveness and Safety of Direct Oral Anticoagulants Compared With Vitamin K Antagonists in Non-Valvular Atrial Fibrillation Patients Undergoing Electrical Cardioversion
Journal of Clinical Trials in Cardiology
Use of Non-Vitamin K Antagonist Oral Anticoagulants 2008-2016: A Danish Nationwide Cohort Study
Basic and Clinical Pharmacology and Toxicology
Medicine
Toxicology
Pharmacology
Role of Non-Vitamin K Oral Anticoagulants for Prevention of Stroke in Renal Impaired Atrial Fibrillation Patients
ACI (Acta Cardiologia Indonesiana)
Overview of the Non-Vitamin K Oral Anticoagulants for Atrial Fibrillation
Therapeutic Advances in Cardiovascular Disease
Cardiovascular Medicine
Pharmacology
Cardiology
Prm20 - Clinical Effectiveness and Safety of Standard-Dose and Low-Dose Non-Vitamin K Antagonist Oral Anticoagulants in Patients With Nonvalvular Atrial Fibrillation: A Nationwide Population-Based Cohort Study
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Quality of INR Control and Switching to Non-Vitamin K Oral Anticoagulants Between Women and Men With Atrial Fibrillation Treated With Vitamin K Antagonists in Spain. A Population-Based, Real-World Study
PLoS ONE
Multidisciplinary